100 employees
PROLOR Biotech develops proprietary versions of already-approved therapeutic proteins.
2001
$30M
from 2 investors over 2 rounds
Modigenetech raised $2.3M on April 1, 2012
Investors: Cybele Holdings
Modigenetech raised $30M on November 1, 2007
Investors: SternAegis Ventures